Stephen Claridge

440 total citations
13 papers, 226 citations indexed

About

Stephen Claridge is a scholar working on Molecular Biology, Organic Chemistry and Hepatology. According to data from OpenAlex, Stephen Claridge has authored 13 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Hepatology. Recurrent topics in Stephen Claridge's work include Liver physiology and pathology (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Stephen Claridge is often cited by papers focused on Liver physiology and pathology (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Stephen Claridge collaborates with scholars based in United Kingdom and Canada. Stephen Claridge's co-authors include Stephen Hanessian, Ulrich Reinhold, Jeffrey M. Besterman, Arkadii Vaisburg, A. Robert MacLeod, Naomy Bernstein, John M. Berge, Elizabeth Tyrrell, Nadine H. Elowe and David B. Llewellyn and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Stephen Claridge

12 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Claridge United Kingdom	8	145	102	21	21	13	13	226
Franck Raeppel France	7	95 0.7×	125 1.2×	17 0.8×	18 0.9×	13 1.0×	11	213
C. Hamlett United Kingdom	4	123 0.8×	67 0.7×	15 0.7×	24 1.1×	10 0.8×	5	188
Richard J. Franklin United Kingdom	11	182 1.3×	165 1.6×	44 2.1×	29 1.4×	15 1.2×	12	339
Stéphane Raeppel United States	10	81 0.6×	185 1.8×	31 1.5×	31 1.5×	21 1.6×	21	258
Johnni Gullo-Brown United States	8	129 0.9×	104 1.0×	63 3.0×	7 0.3×	30 2.3×	8	255
Naomy Bernstein Canada	7	180 1.2×	88 0.9×	31 1.5×	10 0.5×	2 0.2×	7	232
Gregory T. Notte United States	9	118 0.8×	148 1.5×	10 0.5×	21 1.0×	9 0.7×	11	255
Frank T. Coppo United States	7	143 1.0×	190 1.9×	54 2.6×	5 0.2×	8 0.6×	14	388
Ekaterina S. Shchegravina Russia	9	113 0.8×	140 1.4×	12 0.6×	6 0.3×	13 1.0×	30	260
Ruhi Kamran United States	9	69 0.5×	37 0.4×	49 2.3×	21 1.0×	8 0.6×	11	162

Countries citing papers authored by Stephen Claridge

Since Specialization

Citations

This map shows the geographic impact of Stephen Claridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Claridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Claridge more than expected).

Fields of papers citing papers by Stephen Claridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Claridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Claridge. The network helps show where Stephen Claridge may publish in the future.

Co-authorship network of co-authors of Stephen Claridge

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Claridge. A scholar is included among the top collaborators of Stephen Claridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Claridge. Stephen Claridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Dutheuil, Guillaume, Killian Oukoloff, François Lenoir, et al.. (2025). Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models. Journal of Medicinal Chemistry. 68(3). 2981–3003. 7 indexed citations

Beaulieu, Normand, Claire Bonfils, Michael R. Mannion, et al.. (2013). Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies.. Cancer Research. 73(8_Supplement). 930–930. 5 indexed citations

Raeppel, Stéphane, Frédéric Gaudette, Michael R. Mannion, et al.. (2010). Identification of a novel series of potent RON receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(9). 2745–2749. 11 indexed citations

Fournel, Marielle, Isabelle Dupont, Claire Bonfils, et al.. (2010). Abstract 3612: Potent preclinical anti-tumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, in combination with an EGFR inhibitor. Cancer Research. 70(8_Supplement). 3612–3612. 3 indexed citations

Claridge, Stephen, Franck Raeppel, Stéphane Raeppel, et al.. (2009). N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 19(24). 6836–6839. 24 indexed citations

Llewellyn, David B., Naomy Bernstein, Stephen Claridge, et al.. (2009). SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorganic & Medicinal Chemistry Letters. 19(10). 2747–2751. 35 indexed citations

Llewellyn, David B., Stephen Claridge, Naomy Bernstein, et al.. (2009). Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(10). 2742–2746. 44 indexed citations

Beaulieu, Nancy, Isabelle Dupont, Carole Beaulieu, et al.. (2008). 81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials. European Journal of Cancer Supplements. 6(12). 28–28. 3 indexed citations

Hanessian, Stephen, et al.. (2002). The Power of Visual Imagery in Synthesis Planning. Stereocontrolled Approaches to CGP-60536B, a Potent Renin Inhibitor. The Journal of Organic Chemistry. 67(12). 4261–4274. 31 indexed citations

10.

Hanessian, Stephen, et al.. (1998). Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity. Bioorganic & Medicinal Chemistry Letters. 8(16). 2123–2128. 34 indexed citations

11.

Berge, John M., et al.. (1997). A diastereoselective synthesis of benzopyrans using a novel intramolecular Nicholas reaction in the key cyclisation step. Tetrahedron Letters. 38(4). 685–686. 22 indexed citations

12.

Tyrrell, Elizabeth, et al.. (1995). ChemInform Abstract: The Nicholas Reaction. Part 2. An Intramolecular Approach to the Synthesis of Fused Carbocycles.. ChemInform. 26(47). 1 indexed citations

13.

Tyrrell, Elizabeth, et al.. (1995). The Nicholas Reaction: 2. An Intramolecular Approach to the Synthesis of Fused Carbocycles. Synlett. 1995(7). 714–716. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact